常用资源 电子图书期刊论文学位会议外文资源特色专题内部出版物 
Springer电子图书(2)CNKI学位论文(181)知网期刊论文(162)
在“Elsevier电子期刊”中,命中:57条,耗时:小于0.01 秒

在所有数据库中总计命中:345

1.Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
4.Impact of aerobic exercise training during chemotherapy on cancer related cognitive impairments in patients suffering from acute myeloid leukemia or myelodysplastic syndrome — Study protocol of a randomized placebo-controlled trial
作者:P. Zimmera ; 1 ; p.zimmer@dshs-koeln.de" class="auth_mail" title="E-mail the corresponding author ; M. Oberstea ; 1 ; oberstemax@hotmail.com" class="auth_mail" title="E-mail the corresponding author ; W. Blocha ; w.bloch@dshs-koeln.de" class="auth_mail" title="E-mail the corresponding author ; A. Schenka ; a.schenk@dshs-koeln.de" class="auth_mail" title="E-mail the corresponding author ; N. Joistena ; niklasjoisten@hotmail.de" class="auth_mail" title="E-mail the corresponding author ; P. Hartiga ; philipp-hartig@web.de" class="auth_mail" title="E-mail the corresponding author ; F. Wolfa ; flojo.23@arcor.de" class="auth_mail" title="E-mail the corresponding author ; F.T. Baumanna ; f.baumann@dshs-koeln.de" class="auth_mail" title="E-mail the corresponding author ; A. Gartheb ; Alexander.Garthe@dzne.de" class="auth_mail" title="E-mail the corresponding author ; M. Hallekc ; michael.hallek@uni-koeln.de" class="auth_mail" title="E-mail the corresponding author ; T. Elterc ; thomas.elter@uk-koeln.de" class="auth_mail" title="E-mail the corresponding author
刊名:Contemporary Clinical Trials
出版年:2016
5.Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study
作者:Prof Asher Chanan-Khan ; MDa ; Chanan-Khan.Asher@mayo.edu" class="auth_mail" title="E-mail the corresponding author ; Paula Cramer ; MDb ; Fatih Demirkan ; MDc ; Graeme Fraser ; MDd ; Rodrigo Santucci Silva ; MDe ; Prof Sebastian Grosicki ; MDf ; Aleksander Pristupa ; MDg ; Ann Janssens ; MDh ; Prof Jiri Mayer ; MDi ; Prof Nancy L Bartlett ; MDj ; Marie-Sarah Dilhuydy ; MDk ; Halyna Pylypenko ; MDl ; Javier Loscertales ; MDm ; Abraham Avigdor ; MDn ; Prof Simon Rule ; MDo ; Diego Villa ; MDp ; Olga Samoilova ; MDq ; Prof Panagiots Panagiotidis ; MDr ; Andre Goy ; MDs ; Anthony Mato ; MDs ; t ; Miguel A Pavlovsky ; MDu ; Claes Karlsson ; MDv ; Michelle Mahler ; MDw ; Mariya Salman ; PhDw ; Steven Sun ; PhDw ; Charles Phelps ; MSw ; Sriram Balasubramanian ; PhDx ; Angela Howes ; PhDy ; Michael Hallek ; MDz ; for the HELIOS investigators&dagger ;
刊名:The Lancet Oncology
出版年:2016
6.Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study
7.First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial
作者:Dr Barbara Eichhorst ; MDa ; barbara.eichhorst@uk-koeln.de" class="auth_mail" title="E-mail the corresponding author ; Anna-Maria Fink ; MDa ; Jasmin Bahlo ; PhDa ; Raymonde Busch ; Dipl Mathb ; Gabor Kovacs ; MDa ; Christian Maurer ; MDa ; Elisabeth Lange ; MDc ; Prof Hubert K&ouml ; ppler ; MDd ; Prof Michael Kiehl ; MDe ; Martin S&ouml ; kler ; MDf ; Rudolf Schlag ; MDg ; Ursula Vehling-Kaiser ; MDh ; Georg K&ouml ; chling ; MDi ; Christoph Pl&ouml ; ger ; MDj ; Michael Gregor ; MDk ; Torben Plesner ; MDl ; Prof Marek Trneny ; MDm ; Kirsten Fischer ; MDa ; Prof Harmut D&ouml ; hner ; MDn ; Prof Michael Kneba ; MDo ; Prof Clemens-Martin Wendtner ; MDp ; Prof Wolfram Klapper ; MDq ; Prof Karl-Anton Kreuzer ; MDa ; Prof Stephan Stilgenbauer ; MDn ; Sebastian B&ouml ; ttcher ; MDo ; Prof Michael Hallek ; MDa ; r ; on behalf of an international group of investigators
刊名:The Lancet Oncology
出版年:2016
8.Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
10.Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network
作者:Prof Olivier Hermine ; MDa ; d ; &dagger ; ; Eva Hoster ; PhDe ; f ; &dagger ; ; Jan Walewski ; MDg ; André ; Bosly ; MDh ; Stephan Stilgenbauer ; MDi ; Catherine Thieblemont ; MDj ; Michal Szymczyk ; MDg ; Reda Bouabdallah ; MDk ; Prof Michael Kneba ; MDl ; Prof Michael Hallek ; MDm ; Prof Gilles Salles ; MDn ; Pierre Feugier ; MDo ; Vincent Ribrag ; MDp ; Josef Birkmann ; MDq ; Roswitha Forstpointner ; MDe ; Corinne Haioun ; MDr ; Mathias H&auml ; nel ; MDs ; René ; Olivier Casasnovas ; MDt ; J&uuml ; rgen Finke ; MDu ; Norma Peter ; MDv ; Kamal Bouabdallah ; MDw ; Catherine Sebban ; MDx ; Prof Thomas Fischer ; MDy ; Prof Ulrich D&uuml ; hrsen ; MDz ; Bernd Metzner ; MDaa ; Georg Maschmeyer ; MDab ; Prof Lothar Kanz ; MDac ; Christian Schmidt ; MDe ; Richard Delarue ; MDa ; Nicole Brousse ; MDb ; Wolfram Klapper ; MDad ; Prof Elizabeth Macintyre ; PhDc ; Prof Marie-Hé ; ; ne Delfau-Larue ; PhDae ; Christiane Pott ; MDl ; Prof Wolfgang Hiddemann ; MDe ; Michael Unterhalt ; PhDe ; Prof Martin Dreyling ; MDe ; Martin.Dreyling@med.uni-muenchen.de" class="auth_mail" title="E-mail the corresponding author ; on behalf of the European Mantle Cell Lymphoma Network
刊名:The Lancet
出版年:2016
1
2
3
4
5
6
按检索点细分(57)
作者(57)
按出版年细分(57)
2027年及以后(3)
2017年(1)
2016年(9)
2013年(2)
2012年(3)
2011年(13)
2010年(7)
2009年(2)
2008年(1)
2007年(3)
2006年(3)
2003年(1)
2002年(1)
2001年(3)
2000年及以前(5)

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700